XML 74 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Collaborations - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 18, 2019
Jan. 31, 2020
Dec. 31, 2018
Dec. 31, 2021
Dec. 31, 2020
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue       $ 7,338 $ 20,948
Deferred revenue, recognized       2,000  
License          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue         15,100
License | Transfer of Exclusive License and Related Know-How          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue         15,000
Exclusive License          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue         100
Collaboration          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue       7,338 5,848
Collaboration | Reimbursable Out-of-Pocket and Personnel Costs Incurred Related to Research Services          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue       7,300 $ 5,800
ISU Abxis | Amended and Restated License Agreement          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
Regulatory and development milestone payment     $ 2,500 0  
ISU Abxis | Amended and Restated License Agreement | Maximum          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
Milestone payment     19,500 0  
Commercial milestone payments     $ 17,000 0  
Biogen          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
License and collaboration revenue       $ 0  
Biogen | License and Collaboration Agreement (the “Biogen Agreement”)          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
Research services 30 months        
Research services option to extend 12 months        
Biogen | Exclusive License          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
Up-front payments received   $ 15,000      
Biogen | Exclusive License | Maximum          
Revenue Recognition Multiple Deliverable Arrangements [Line Items]          
Development and sales milestone payments   $ 340,000